Core Viewpoint - MicroPort Robotics has released a strong positive earnings forecast for the fiscal year 2025, indicating a revenue growth of 110% to 120%, surpassing Citigroup's expectation of 100% and market expectation of 94% [1] Group 1: Financial Performance - Adjusted net loss is expected to narrow by over 50%, aligning with expectations [1] - The revenue exceeding expectations is highlighted as a key point, confirming that the company is in a phase of rapid global business expansion [1] Group 2: Market Dynamics - The surge in overseas orders for the Tumi robot is projected to exceed 100 units in fiscal year 2025, surpassing the previous guidance of 70 to 80 units provided in August, which offers excellent visibility for revenue conversion in fiscal year 2026 [1] - The market reacted positively to the newly released "Guidelines for the Project Establishment of Pathological Medical Service Pricing (Trial)" on January 21, leading to a rise in stock prices for MicroPort Robotics and its peers [1] Group 3: Industry Outlook - Citigroup views the new policy as a milestone that reduces commercialization path risks and provides a clear and unified framework for industry growth [1] - Citigroup has assigned a "Buy" rating to MicroPort Robotics with a target price of HKD 32 [1]